All In Biotech

Drug Trial Radar · NCT02836873

Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment

A Double Blind Placebo Controlled Study to Evaluate the Effect of Bexagliflozin Tablets on Hemoglobin A1c in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment

Last checked: Nov 20, 2026Latest source record: Jun 30, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 312 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

312

Actual

Start

Sep 23, 2016

Primary completion

Jan 11, 2018

Study completion Jan 11, 2018

Sponsor

Lead sponsor
TheracosIndustry
Sponsor type
Industry
First posted
Jul 19, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This was a phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of oral administration of bexagliflozin at 20 mg versus placebo in subjects with T2DM, moderate renal impairment and inadequate glycemic control.

Conditions

  • Type 2 Diabetes Mellitus

Interventions

  • BexagliflozinDrug

    Bexagliflozin tablet, 20 mg

  • PlaceboDrug

    Placebo (inactive) tablet to match the active comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in HbA1c at 24 WeeksTime frame: 24 weeks

Locations

56 sites in 4 countries. Site status is shown where the registry gives one.

  • Research Site

    Fresno, California

  • Research Site

    La Palma, California

  • Research Site

    Lincoln, California

  • Research Site

    Riverside, California

  • Research Site

    Sacramento, California

  • Research Site

    San Dimas, California

  • Research Site

    Monument, Colorado

  • Research Site

    Norwalk, Connecticut

  • Research Site

    Hollywood, Florida

  • Research Site

    Tampa, Florida

  • Research Site

    West Palm Beach, Florida

  • Research Site

    Paducah, Kentucky

  • Research Site

    Auburn, Maine

  • Research Site

    Rockport, Maine

  • Research Site

    Nashua, New Hampshire

  • Research Site

    The Bronx, New York

  • Research Site

    Stow, Ohio

  • Research Site

    Oklahoma City, Oklahoma

  • Research Site

    Austin, Texas

  • Research Site

    Austin, Texas

  • Research Site

    North Richland Hills, Texas

  • Research Site

    Round Rock, Texas

  • Research Site

    San Antonio, Texas

  • Research Site

    Dijon, France

  • Research Site

    Paris, France

  • Research Site

    Paris, France

  • Research Site

    Paris, France

  • Research Site

    Pierre-Bénite, France

  • Research Site

    Poitiers, France

  • Research Site

    Vénissieux, France

  • Research Site

    Atsugi-shi, Kanagawa, Japan

  • Research Site

    Kamakura-shi, Kanagawa, Japan

  • Research Site

    Kawasaki-shi, Kanagawa, Japan

  • Research Site

    Yokohama, Kanagawa, Japan

  • Research Site

    Yokohama, Kanagawa, Japan

  • Research Site

    Yokohama, Kanagawa, Japan

  • Research Site

    Kyoto, Kyoto, Japan

  • Research Site

    Kyoto, Kyoto, Japan

  • Research Site

    Kawagoe-shi, Saitama, Japan

  • Research Site

    Kawaguchi-shi, Saitama, Japan

Showing 40 of 56 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.